KY-05009

KY-05009

Biochem/physiol Actions

KY-05009 is a Traf2- and Nck-interacting kinase (TNIK) inhibitor that inhibits the epithelial-to-mesenchymal transition (EMT) in cancer cells.

KY-05009 is also known as (5-(4-methylbenzamido)-2-(phenylamino) thiazole-4-carboxamide). It prevents the proliferation induced by interleukin-6 and promotes cell death by blocking Wnt signaling in multiple myeloma (MM) cells. KY-05009 is a novel aminothiazole, which possesses anti-cancer activity in human colorectal cancer cells. KY-05009 prevents migration and invasion stimulated by TGF-?1 (transforming growth factor beta 1).

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3575000 KY-05009 light yellow to dark yellow 100 WCEDGRTWDSHZHF-UHFFFAOYSA-N 1S/C18H16N4O2S/c1-11-7-9-12(10-8-11)16(24)22-17-14(15(19)23)21-18(25-17)20-13-5-3-2-4-6-13/h2-10H,1H3,(H2,19,23)(H,20,21)(H,22,24) SIGMA-ALDRICH DMSO: 10 mg/mL, clear powder ≥98% (HPLC)
£468.00 (exc VAT) per 25MG
-
+
3575001 KY-05009 light yellow to dark yellow 100 WCEDGRTWDSHZHF-UHFFFAOYSA-N 1S/C18H16N4O2S/c1-11-7-9-12(10-8-11)16(24)22-17-14(15(19)23)21-18(25-17)20-13-5-3-2-4-6-13/h2-10H,1H3,(H2,19,23)(H,20,21)(H,22,24) SIGMA-ALDRICH DMSO: 10 mg/mL, clear powder ≥98% (HPLC)
£161.57 (exc VAT) per 5MG
-
+